Latest On-Demand Webinars & Online Events

In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.

During this webinar, you will discover ways to improve your protein extraction, such as by reducing workflow complexity, improving results from scarce samples, setting up robust assays and working with large sample cohorts.

Design–build–test–learn (DBTL) cycles are commonly used in biotechnology and in natural product discovery as they provide a systemic and efficient framework for the metabolic engineering of microbes.

A novel platform that automates multiomics analyses of microbes could enable faster and better DBLT cycles for your research. In this webinar, the development and validation of the high-throughput, automated platform using model microbial organisms is described, as well as the recent work in applying the platform to cell factory and natural products engineering.

Most organizations now recognize digitalization as a necessity for the lab of the future, yet many find it difficult to justify the expense, get stakeholder buy-in, or move the process forward. The delay carries significant risks – anything from untraceable data, lost protocols, to non-compliance of regulatory requirements on data integrity. It also takes away the opportunities to automate, scale up, and integrate lab processes efficiently.

Detailed and sensitive characterization of ionizable lipids that make up lipid nanoparticles (LNP) and their related impurities is necessary to ensure the quality of mRNA therapies. Additionally, there are mRNA quality attributes such as 5’ capping that directly impact efficacy and safety.

Speaking at the Vaccine Research & Development 2022, Kyle Luttgeharm, PhD, Product Manager from Agilent presented their talk on IVT RNA production and
accurate and precise mRNA analysis.

Speaking at the Vaccine Research & Development 2022, Jorge Armero Gimenez from Wageningen University & Research, presented their talk on Virus-Like Particles immunogenicity in human dendritic cells.

The Problem
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.